PTAB challenges

Proceedings overview

US patent 8863319 has been involved in one AIA trial proceeding, IPR2025-01029, which resulted in a discretionary denial of institution. This means that all claims of the patent remain intact and untested by the PTAB. This gives a defendant a stronger defensive posture if they are contemplating an IPR, as the patent claims have not been challenged on the merits in an AIA trial.

IPR2025-01029 — REVELYST SALES LLC et al. v. Robert T. Knight

• Type: Inter Partes Review
• Filed: 2025-07-09
• Status: Discretionary Denial
• Judge panel: Not publicly available from the provided data.
• Petition grounds: Not publicly available from the provided data.
• Institution decision: Denied - 2025-12-23. The denial was procedural, based on the existence of a co-pending district court litigation (Brainguard Technologies, Inc. v. Revelyst Sales LLC, Case No. 8:24-cv-02652 in the California Central District Court), which was a critical factor in the Patent Trial and Appeal Board's (PTAB) discretionary denial of institution. [cite: The Google Patents page for US8863319]
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable, as institution was denied.
• Appeal: Not applicable, as institution was denied.
• Defensive value: Patent owner prevailed at the institution stage. This means all claims of US8863319 remain unadjudicated by the PTAB. Any infringement theory built on these claims has not been challenged in an IPR. A defendant facing assertion of this patent today would need to consider alternative invalidity strategies or file a new IPR, potentially addressing the PTAB's discretionary denial factors.

Strategic summary

All claims (1-20) of US8863319 are currently SUSTAINED and UNTESTED at the PTAB, as the sole IPR filed against the patent, IPR2025-01029, was discretionarily denied institution. This means no claims were invalidated, nor were any found patentable, as the merits of the petition were not reached.

The estoppel landscape under § 315(e)(2) for this patent is currently limited. Since institution was denied, the petitioner (REVELYST SALES LLC et al.) and their privies are not estopped from raising the same or reasonably could have raised prior art grounds in district court or future PTAB proceedings, as no final written decision on the merits was issued. For a defendant currently being asserted against, this means all prior-art grounds remain available for challenge, subject to other procedural bars.

There is no discernible pattern of multiple IPRs filed by the same petitioner or aggressive PTAB appeals by the patent owner from the provided information. Unified Patents was the petitioner for IPR2025-01029, which indicates a defensive aggregator's involvement in challenging the patent.

Recommended next steps

The IPR was discretionarily denied institution due to a co-pending district court litigation. If you are a defendant, you should review the PTAB's institution denial decision for IPR2025-01029 to understand the specific reasoning and factors that led to the denial, particularly in relation to the district court case. This can inform strategies for a new IPR filing, potentially addressing the issues that led to the discretionary denial. The PTAB E2E portal would contain the institution decision (https://e2e.uspto.gov/ptab/#!/dashboard/search/patent/8863319).